Virus

Unchained Labs jumps into gene therapy and vaccines with new AAV stability application!

Wednesday, April 1, 2020 - 1:00pm

Uncle is already the gold standard for measuring protein stability and, with this new application, jumps in to support researchers in pursuit of novel gene therapies and better vaccines.

Key Points: 
  • Uncle is already the gold standard for measuring protein stability and, with this new application, jumps in to support researchers in pursuit of novel gene therapies and better vaccines.
  • Many gene therapies, immunotherapies and vaccines being developed use adeno-associated viruses or AAVs.
  • A stable AAV stays intact until it finds its target and won't aggregate-or worse, leak potentially toxic DNA into the body.
  • "With this new application, Uncle lends a helping hand to researchers working on life-changing gene therapies and vaccines," said Taegen Clary, VP of Marketing at Unchained Labs.

Unchained Labs jumps into gene therapy and vaccines with new AAV stability application!

Wednesday, April 1, 2020 - 1:00pm

Uncle is already the gold standard for measuring protein stability and, with this new application, jumps in to support researchers in pursuit of novel gene therapies and better vaccines.

Key Points: 
  • Uncle is already the gold standard for measuring protein stability and, with this new application, jumps in to support researchers in pursuit of novel gene therapies and better vaccines.
  • Many gene therapies, immunotherapies and vaccines being developed use adeno-associated viruses or AAVs.
  • A stable AAV stays intact until it finds its target and won't aggregate-or worse, leak potentially toxic DNA into the body.
  • "With this new application, Uncle lends a helping hand to researchers working on life-changing gene therapies and vaccines," said Taegen Clary, VP of Marketing at Unchained Labs.

Global Virus Filtration Market Analysis, Trends, and Forecasts 2019-2025 - ResearchAndMarkets.com

Wednesday, April 1, 2020 - 10:42am

The "Virus Filtration - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Virus Filtration - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
  • The Virus Filtration market worldwide is projected to grow by US$3.2 Billion, driven by a compounded growth of 12.5%.
  • Kits & Reagents, one of the segments analyzed and sized in this study, displays the potential to grow at over 13.4%.
  • Poised to reach over US$3.3 Billion by the year 2025, Kits & Reagents will bring in healthy gains adding significant momentum to global growth.

GreyScan Announces Development of First Fieldable Trace Virus Detector (TVD-1)

Tuesday, March 31, 2020 - 6:02pm

WILMINGTON, Del., March 31, 2020 /PRNewswire/ --Joining the global fight against the COVID-19 virus, GreyScan has officially launched development of the TVD-1, the world's first fieldable trace virus detector.

Key Points: 
  • WILMINGTON, Del., March 31, 2020 /PRNewswire/ --Joining the global fight against the COVID-19 virus, GreyScan has officially launched development of the TVD-1, the world's first fieldable trace virus detector.
  • The TVD-1 will be the first fieldable, fast, and reliable screening instrument able to detect the presence of the SARS-CoV-2 virus on surfaces in community settings (including offices, transportation, day care, and schools) at trace levels.
  • We are partnering with experts from across the globe to enhance our technology to expose trace contaminants of pathogens on surfaces.
  • At GreyScan, whether we are testing for a virus or an explosive, our entire team is committed to keeping people safe as they go about their everyday lives," added Ollerton.

Ostrich Pharma USA Produces Antibodies to Block the Virus that Causes COVID-19

Tuesday, March 31, 2020 - 9:39pm

Ostrich Pharma USA has announced the successful development of ostrich antibodies to the SARS-CoV-2 virus, the expanding use of those antibodies in Japan, and plans for producing and deploying the antibodies in the U.S.

Key Points: 
  • Ostrich Pharma USA has announced the successful development of ostrich antibodies to the SARS-CoV-2 virus, the expanding use of those antibodies in Japan, and plans for producing and deploying the antibodies in the U.S.
    Dr. Yasuhiro Tsukamoto, Dean of the Graduate School of Life and Environmental Sciences at Kyoto Prefectural University and Co-CEO of Ostrich Pharma USA, has injected a genetically engineered pseudovirus into ostriches, and antibodies were purified from their eggs.
  • We were even more pleased to see how capable the antibodies were in blocking the virus that causes COVID-19.
  • Ten ostriches have been vaccinated, and the antibodies from their eggs have already been used in masks, nasal drops, and candies in Japan.
  • According to Ostrich Pharma USA Co-CEO Stuart Greenberg, We recognize the enormous need for multiple approaches to the COVID-19 pandemic in the US.

DigiFlex, a PV Nano Cell Subsidiary, Submits to the Israeli Innovation Authority a Proposal to Develop a Break-through Protective Technology against the Coronavirus (COVID-19)

Tuesday, March 31, 2020 - 3:54pm

DigiFlex, a wholly owned subsidiary of PV Nano Cell, has today submitted to the Israeli Innovation Authority a proposal to develop a protective technology against the coronavirus and possibly additional viruses.

Key Points: 
  • DigiFlex, a wholly owned subsidiary of PV Nano Cell, has today submitted to the Israeli Innovation Authority a proposal to develop a protective technology against the coronavirus and possibly additional viruses.
  • The proposed technology is both cost efficient and can easily be used by the general population.
  • The company is planning to use PV Nano Cell's patented conductive silver and copper inks - SicrysTM that are Single Nano Crystals based.
  • Our single crystal technology combined with our complete solution approach know-how will enable us to quickly develop the first products.

International Learning Community Pandemic Global Scan - Webinar Tuesday, March 31st

Monday, March 30, 2020 - 9:40pm

SARATOGA SPRINGS, N.Y., March 30, 2020 /PRNewswire-PRWeb/ -- The MASIE Center's Learning CONSORTIUM, with i4cp and other global learning collaboratives, is hosting the International Learning Community Pandemic Global Scan on Tuesday morning, March 31st at 7:00 am ET.

Key Points: 
  • SARATOGA SPRINGS, N.Y., March 30, 2020 /PRNewswire-PRWeb/ -- The MASIE Center's Learning CONSORTIUM, with i4cp and other global learning collaboratives, is hosting the International Learning Community Pandemic Global Scan on Tuesday morning, March 31st at 7:00 am ET.
  • Elliott Masie, Nigel Paine, and other global learning colleagues will discuss the local and global impact of the pandemic on the workforce and its learners worldwide in this 90-minute global Video Touchbase, as well as pose live questions to the group.
  • Reserve your virtual space in the International Learning Community Pandemic Global Scan webinar here: https://masie.zoom.us/webinar/register/WN_HrcZwPVKR8GDzYMWZGEkeA
    The webinar will include a 2-3-minute update overview from each represented region about the following elements:
    The Status of the Coronavirus's Impact on Work in their Country: Are People Working from Home?
  • Please join this important dialogue: International Learning Community Pandemic Global Scan webinar - Tuesday, March 31st at 7:00am ET.

2020 Insights on the Global Market for Antimicrobial, Antiviral and Antifungal Nanocoatings - When the Current COVID-19 Crisis Has Ended Efforts Must Turn to Future Preventative Measures - ResearchAndMarkets.com

Monday, March 30, 2020 - 4:24pm

The "The Global Market for Antimicrobial, Antiviral and Antifungal Nanocoatings 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Global Market for Antimicrobial, Antiviral and Antifungal Nanocoatings 2020" report has been added to ResearchAndMarkets.com's offering.
  • When the current global crisis has abated, efforts must turn to future preventative measures.
  • Nanocoatings can demonstrate up to 99.9998% effectiveness against bacteria, formaldehyde, mold and viruses and are up to 1000 times more efficient than previous technologies available on the market.
  • Nanocoatings companies are already partnering with global manufacturers and cities to develop anti-viral facemasks, hazard suits and easily applied surface coatings.

Alliance Resource Partners, L.P. Announces Actions In Response to Effects of COVID-19 Pandemic

Monday, March 30, 2020 - 12:00pm

Alliance Resource Partners, L.P. (NASDAQ: ARLP) today announced a series of actions in response to the rapidly evolving impact of the COVID-19 pandemic.

Key Points: 
  • Alliance Resource Partners, L.P. (NASDAQ: ARLP) today announced a series of actions in response to the rapidly evolving impact of the COVID-19 pandemic.
  • The unprecedented decision by world leaders to lockdown the global economy to combat the deadly virus has crushed demand for energy.
  • All Americans are having to adjust to a way of life none of us could have imagined two months ago.
  • For the past six weeks, however, we have been working at reduced levels while evaluating the needs of our customers amid the disruptions caused by the pandemic.

Steadman Philippon Research Institute Working to Find New Testing Methods for COVID-19

Saturday, March 28, 2020 - 3:00pm

SPRI is working to expedite research and testing of potential new methods used to test individuals for the virus.

Key Points: 
  • SPRI is working to expedite research and testing of potential new methods used to test individuals for the virus.
  • The focus of the testing is on individuals who have no idea they have contracted COVID-19.
  • Huard has a few potential new testing options in development, with research that is ongoing and not yet approved by the Food and Drug Administration (FDA).
  • Sometimes you have to be ahead of the curve in searching for new methods of testing and treating new viruses and illnesses.